Skip to main content
SpringerLink
Log in

The Role of Angioinfarction in the Management of Renal Tumors

  • Chapter
Clinical Management of Renal Tumors

  • 770 Accesses

Abstract

Hypervascularity is a radiographic and pathologic hallmark of most solid tumors of the kidney. Angioinfarction targets the end product of altered angiogenesis pathways by eliminating the tumor’s blood supply. Angioinfarction of renal tumors may be used to both the surgeon’s and patient’s advantage. Here we review the history, indications, techniques, and complications of angioinfarction in the management of primary renal tumors and their metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Truss MC, Stief CG, Jonas U. Werner Forssmann: surgeon, urologist, and Nobel Prize winner. World J Urol 1999;17(3):184–186.

    Article  PubMed  CAS  Google Scholar 

  2. Braun MN, AA, Vogelzang RL. Embolization. In: Interventional Radiology Procedure Manual, 1st ed. New York: Churchill Livingstone, 1997:272.

    Google Scholar 

  3. Klimberg I, Hunter P, Hawkins IF, Drylie DM, Wajsman Z. Preoperative angioinfarction of localized renal cell carcinoma using absolute ethanol. J Urol 1985;133(1):21–24.

    PubMed  CAS  Google Scholar 

  4. Ward JFaV, Thomas E. Transcatheter therapeutic embolization of genitourinary pathology. Rev Urol 2000;2:236–245.

    PubMed  CAS  Google Scholar 

  5. Coldwell DM, Stokes KR, Yakes WF. Embolotherapy: agents, clinical applications, and techniques. Radiographics 1994;14(3):623–643; quiz 645–646.

    PubMed  CAS  Google Scholar 

  6. Uflacker R. Embolization Procedures: Techniques and Materials. New York: McGraw-Hill, 1991.

    Google Scholar 

  7. Jafri SZ, Ellwood RA, Amendola MA, Farah J. Therapeutic angioinfarction of renal carcinoma: CT follow-up. J Comput Assist Tomogr 1989;13(3):443–447.

    PubMed  CAS  Google Scholar 

  8. Munro NP, Woodhams S, Nawrocki JD, Fletcher MS, Thomas PJ. The role of transarterial embolization in the treatment of renal cell carcinoma. BJU Int 2003;92(3):240–244.

    Article  PubMed  CAS  Google Scholar 

  9. Demirci D, Tatlisen A, Ekmekcioglu O, Ozcan N, Kaya R. Does radical nephrectomy with immunochemotherapy have any superiority over embolization alone in metastatic renal cell carcinoma? A preliminary report. Urol Int 2004;73(1):54–58.

    Article  PubMed  CAS  Google Scholar 

  10. Sweeney P, Wood CG, Pisters LL, et al. Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urol Oncol 2003;21(5):327–333.

    PubMed  Google Scholar 

  11. Swanson DA, Johnson DE, von Eschenbach AC, Chuang VP, Wallace S. Angioinfarction plus nephrectomy for metastatic renal cell carcinoma—an update. J Urol 1983;130(3):449–452.

    PubMed  CAS  Google Scholar 

  12. Mebust WK, Weigel JW, Lee KR, Cox GG, Jewell WR, Krishnan EC. Renal cell carcinoma—angio-infarction. J Urol 1984;131(2):231–235.

    PubMed  CAS  Google Scholar 

  13. Neves RJ, Zincke H. Surgical treatment of renal cancer with vena cava extension. Br J Urol 1987;59(5):390–395.

    Article  PubMed  CAS  Google Scholar 

  14. Nesbitt JC, Soltero ER, Dinney CP, et al. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg 1997;63(6):1592–1600.

    Article  PubMed  CAS  Google Scholar 

  15. Heye S, Maleux G, Van Poppel H, Oyen R, Wilms G. Hemorrhagic complications after nephronsparing surgery: angiographic diagnosis and management by transcatheter embolization. AJR Am J Roentgenol 2005;184(5):1661–1664.

    PubMed  Google Scholar 

  16. Albani JM, Novick AC. Renal artery pseudoaneurysm after partial nephrectomy: three case reports and a literature review. Urology 2003;62(2):227–231.

    Article  PubMed  Google Scholar 

  17. Bauer SB. Anomalies of the upper urinary tract. In: Walsh P, ed. Campbell’s Urology, 8th ed., vol 3. Philadelphia: Saunders, 2002:1885–1925.

    Google Scholar 

  18. Wakefield M. Renal arteriovenous malformation. E-Medicine, 2004. www.emedicine.com/med/topic2861.htm.

    Google Scholar 

  19. Maldonado JE, Sheps SG, Bernatz PE, Deweerd JH, Harrison EG Jr. Renal arteriovenous fistula. A reversible cause of hypertension and heart failure. Am J Med 1964;37:499–513.

    Article  PubMed  CAS  Google Scholar 

  20. Crummy AB Jr, Atkinson RJ, Caruthers SB Jr. Congenital renal arteriovenous fistulas. J Urol 1965;93:24–26.

    PubMed  Google Scholar 

  21. Cho KJ, Stanley JC. Non-neoplastic congenital and acquired renal arteriovenous malformations and fistulas. Radiology 1978;129(2):333–343.

    PubMed  CAS  Google Scholar 

  22. Yazaki T, Tomita M, Akimoto M, Konjiki T, Kawai H, Kumazaki T. Congenital renal arteriovenous fistula: case report, review of Japanese literature and description of non-radical treatment. J Urol 1976;116(4):415–418.

    PubMed  CAS  Google Scholar 

  23. Thomason WB, Gross M, Radwin HM, Hulse CM, Dobbs RM Jr. Intrarenal arteriovenous fistulas. J Urol 1972;108(4):526–529.

    PubMed  CAS  Google Scholar 

  24. Messing E, Kessler R, Kavaney PB. Renal arteriovenous fistulas. Urology 1976;8(2):101–107.

    Article  PubMed  CAS  Google Scholar 

  25. McAlhany JC Jr, Black HC Jr, Hanback LD Jr, Yarbrough DR 3rd. Renal arteriovenous fistula as a cause of hypertension. Am J Surg 1971;122(1):117–120.

    Article  PubMed  Google Scholar 

  26. Honda H, Onitsuka H, Naitou S, et al. Renal arteriovenous malformations: CT features. J Comput Assist Tomogr 1991;15(2):261–264.

    Article  PubMed  CAS  Google Scholar 

  27. Yakes WF, Luethke JM, Merland JJ, et al. Ethanol embolization of arteriovenous fistulas: a primary mode of therapy. J Vasc Intervent Radiol 1990;1(1):89–96.

    Article  CAS  Google Scholar 

  28. Clouse ME, Adams DF. Congenital renal arteriovenous malformation: angiography in its diagnosis. Urology 1975;5(2):282–285.

    Article  PubMed  CAS  Google Scholar 

  29. Yakes WF, Haas DK, Parker SH, et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology 1989;170(3 pt 2):1059–1066.

    PubMed  CAS  Google Scholar 

  30. Takebayashi S, Hosaka M, Kubota Y, Ishizuka E, Iwasaki A, Matsubara S. Transarterial embolization and ablation of renal arteriovenous malformations: efficacy and damages in 30 patients with long-term followup. J Urol 1998;159(3):696–701.

    Article  PubMed  CAS  Google Scholar 

  31. Crotty KL, Orihuela E, Warren MM. Recent advances in the diagnosis and treatment of renal arteriovenous malformations and fistulas. J Urol 1993;150(5 pt 1):1355–1359.

    PubMed  CAS  Google Scholar 

  32. Olerud C, Jonsson B. Surgical palliation of symptomatic spinal metastases. Acta Orthop Scand 1996;67(5):513–522.

    Article  PubMed  CAS  Google Scholar 

  33. Manke C, Bretschneider T, Lenhart M, et al. Spinal metastases from renal cell carcinoma: effect of preoperative particle embolization on intraoperative blood loss. AJNR Am J Neuroradiol 2001;22(5):997–1003.

    PubMed  CAS  Google Scholar 

  34. Chatziioannou AN, Johnson ME, Pneumaticos SG, Lawrence DD, Carrasco CH. Preoperative embolization of bone metastases from renal cell carcinoma. Eur Radiol 2000;10(4):593–596.

    Article  PubMed  CAS  Google Scholar 

  35. Nurmi M, Satokari K, Puntala P. Renal artery embolization in the palliative treatment of renal adenocarcinoma. Scand J Urol Nephrol 1987;21(2):93–96.

    PubMed  CAS  Google Scholar 

  36. Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002;168(4 pt 1):1315–1325.

    PubMed  Google Scholar 

  37. Kothary N, Soulen MC, Clark TW, et al. Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Intervent Radiol 2005;16(1):45–50.

    Google Scholar 

  38. Morales JP, Georganas M, Khan MS, Dasgupta P, Reidy JF. Embolization of a bleeding renal angiomyolipoma in pregnancy: case report and review. Cardiovasc Intervent Radiol 2005; 28(2):265–268.

    Article  PubMed  Google Scholar 

  39. Nakada T, Koike H, Katayama T. Changes of vasoactive substances following embolization for renal cell carcinoma. Int Urol Nephrol 1988;20(6):569–576.

    Article  PubMed  CAS  Google Scholar 

  40. Bakke A, Gothlin JH, Haukaas SA, Kalland T. Augmentation of natural killer cell activity after arterial embolization of renal carcinomas. Cancer Res 1982;42(9):3880–3883.

    PubMed  CAS  Google Scholar 

  41. Nakano H, Nihira H, Toge T. Treatment of renal cancer patients by transcatheter embolization and its effects on lymphocyte proliferative responses. J Urol 1983;130(1):24–27.

    PubMed  CAS  Google Scholar 

  42. Lammer J, Justich E, Schreyer H, Pettek R. Complications of renal tumor embolization. Cardiovasc Intervent Radiol 1985;8(1):31–35.

    Article  PubMed  CAS  Google Scholar 

  43. Goldstein HM, Medellin H, Beydoun MT, et al. Transcatheter embolization of renal cell carcinoma. Am J Roentgenol Radium Ther Nucl Med 1975;123(3):557–562.

    PubMed  CAS  Google Scholar 

  44. Rabe FE, Yune HY, Richmond BD, Klatte EC. Renal tumor infarction with absolute ethanol. AJR Am J Roentgenol 1982;139(6):1139–1144.

    PubMed  CAS  Google Scholar 

  45. Zielinski H, Szmigielski S, Petrovich Z. Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma. Am J Clin Oncol 2000; 23(1):6–12.

    Article  PubMed  CAS  Google Scholar 

  46. Klimberg IW, Locke DR, Hawkins IF Jr, Drylie DM. Absolute ethanol renal angioinfarction for control of hypertension. Urology 1989;33(2):153–158.

    Article  PubMed  CAS  Google Scholar 

  47. Wells IP, Hammonds JC, Franklin K. Embolisation of hypernephromas: a simple technique using ethanol. Clin Radiol 1983;34(6):689–692.

    Article  PubMed  CAS  Google Scholar 

  48. Lanigan D, Jurriaans E, Hammonds JC, Wells IP, Choa RG. The current status of embolization in renal cell carcinoma—a survey of local and national practice. Clin Radiol 1992;46(3):176–178.

    Article  PubMed  CAS  Google Scholar 

  49. Chuang VP, Wallace S, Swanson DA. Technique and complications of renal carcinoma infarction. Urol Radiol 1981;2(3):223–228.

    Article  PubMed  CAS  Google Scholar 

  50. Zagler A, Azadpour M, Mercado C, Hennekens CH. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J 2006;151(1):140–145.

    Article  PubMed  CAS  Google Scholar 

  51. Morcos SK. Prevention of contrast media-induced nephrotoxicity after angiographic procedures. J Vasc Intervent Radiol 2005;16(1):13–23.

    Google Scholar 

  52. Hemingway AP, Allison DJ. Complications of embolization: analysis of 410 procedures. Radiology 1988;166(3):669–672.

    PubMed  CAS  Google Scholar 

  53. Jacobson AI, Amukele SA, Marcovich R, et al. Efficacy and morbidity of therapeutic renal embolization in the spectrum of urologic disease. J Endourol 2003;17(6):385–391.

    Article  PubMed  Google Scholar 

  54. Bissler JJ, Racadio J, Donnelly LF, Johnson ND. Reduction of postembolization syndrome after ablation of renal angiomyolipoma. Am J Kidney Dis 2002;39(5):966–971.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Fox Chase Cancer Center, Philadelphia, PA

    Bryan T. Kansas MD & Paul L. Crispen MD

  2. Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, PA

    Robert G. Uzzo MD

Authors
  1. Bryan T. Kansas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul L. Crispen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert G. Uzzo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH

    Ronald M. Bukowski MD

  2. Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH

    Andrew C. Novick MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Kansas, B.T., Crispen, P.L., Uzzo, R.G. (2008). The Role of Angioinfarction in the Management of Renal Tumors. In: Bukowski, R.M., Novick, A.C. (eds) Clinical Management of Renal Tumors. Humana Press. https://doi.org/10.1007/978-1-60327-149-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-149-3_15

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-251-3

  • Online ISBN: 978-1-60327-149-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation